# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-23-002197
Filing Date
2023-11-27
Accepted
2023-11-27 16:30:41
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | e5240_10k.htm iXBRL | 10-K | 2175259
2 | EXHIBIT 14.1 | e5240_ex14-1.htm | EX-14.1 | 154038
3 | EXHIBIT 21.1 | e5240_ex21-1.htm | EX-21.1 | 2670
4 | EXHIBIT 23.1 | e5240_ex23-1.htm | EX-23.1 | 2511
5 | EXHIBIT 23.2 | e5240_ex23-2.htm | EX-23.2 | 3583
6 | EXHIBIT 31.1 | e5240_ex31-1.htm | EX-31.1 | 17617
7 | EXHIBIT 31.2 | e5240_ex31-2.htm | EX-31.2 | 17088
8 | EXHIBIT 32.1 | e5240_ex32-1.htm | EX-32.1 | 8905
9 | EXHIBIT 97.1 | e5240_ex97-1.htm | EX-97.1 | 36412
10 | GRAPHIC | image_001.gif | GRAPHIC | 25732
11 | GRAPHIC | image_002.gif | GRAPHIC | 23282
| Complete submission text file | 0001731122-23-002197.txt |  | 6316302

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | avxl-20230930.xsd | EX-101.SCH | 35227
13 | XBRL CALCULATION FILE | avxl-20230930_cal.xml | EX-101.CAL | 33039
14 | XBRL DEFINITION FILE | avxl-20230930_def.xml | EX-101.DEF | 98864
15 | XBRL LABEL FILE | avxl-20230930_lab.xml | EX-101.LAB | 256282
16 | XBRL PRESENTATION FILE | avxl-20230930_pre.xml | EX-101.PRE | 195832
52 | EXTRACTED XBRL INSTANCE DOCUMENT | e5240_10k_htm.xml | XML | 816477

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 231440632
SIC: 2836 Biological Products, (No Diagnostic Substances)